Published 12:30 am Thursday, January 22, 2015
By Emily Ford
For the Duke Translational Medicine Institute
A Raleigh medical practice has enrolled its 100th patient into a Duke University health research project working to end multiple sclerosis.
Raleigh Neurology Associates recently reached the 100-patient milestone for the MURDOCK Multiple Sclerosis Study, a long-term health research project based at the North Carolina Research Campus in Kannapolis. Raleigh Neurology partnered with Duke in July 2014 to help recruit 1,000 people with multiple sclerosis and 100 people with Primary Progressive MS.
Dr. Simon Gregory is principal investigator for the MURDOCK Multiple Sclerosis Study and associate professor at the Duke Molecular Physiology Institute at Duke University School of Medicine. He and his team are working to identify the genetic underpinnings of complex diseases like MS and understand disease development and progression at the molecular level.
While Duke recruits MS patients at several locations in North Carolina, Raleigh Neurology is the only independent enrollment site for the MURDOCK Study and enrolls between six and eight patients per week.
~~~~~~~~~~~~~~~~~~~~
.
.
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews